Awards Nomination 20+ Million Readerbase
Indexed In
  • Academic Journals Database
  • Open J Gate
  • Genamics JournalSeek
  • JournalTOCs
  • China National Knowledge Infrastructure (CNKI)
  • Scimago
  • Ulrich's Periodicals Directory
  • RefSeek
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • Publons
  • MIAR
  • University Grants Commission
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • Google Scholar
Share This Page

Editor-in-Chief

TKS Mukkur

TKS Mukkur
Editor-in-Chief
Associate Professor, School of Biomedical Sciences
Curtin University of Technology, Australia

Biography

Dr. TKS Mukkur is a Fellow of the Australian Society of Microbiology. He conducted research at institutions noted worldwide including Stanford University School of Medicine, Harvard University Medical School and Washington University in St Louis, Missouri, St Louis, USA and he have a total of 105 publications and supervised the research of 30 students [postgraduate + BSc (Hons)] and have held academic and/or research positions in Canadian and Australian organisations including CSIRO and universities. His major research interests are i)Identification of immunomodulatory and bacterial biofilm dispersing agents from traditional medicinal plants of different ethno-botanical origins and to ii)Apply modern life sciences technologies for development of diagnostic assays, discovery of novel antimicrobials and affordable non−invasive vaccines for infectious diseases of humans and animals, using live attenuated bacterial pathogens as vaccines and deliver vectors for heterologous antigens including tumour-associated and tumour-specific antigens.

Research Interest

His major research interests are i)Identification of immunomodulatory and bacterial biofilm dispersing agents from traditional medicinal plants of different ethno-botanical origins and to ii)Apply modern life sciences technologies for development of diagnostic assays, discovery of novel antimicrobials and affordable non−invasive vaccines for infectious diseases of humans and animals, using live attenuated bacterial pathogens as vaccines and deliver vectors for heterologous antigens including tumour-associated and tumour-specific antigens.